Page last updated: 2024-08-05 11:05:28
oxo monocarboxylic acid
Any monocarboxylic acid having at least one additional oxo functional group.
ChEBI ID: 35871
Members (8)
Member | Definition | Role |
---|---|---|
17-phenyltrinorprostaglandin e2 | A prostanoid that is 18,19,20-trinor-prostaglandin E2 in which one of the terminal methyl hydrogens has been replaced by a phenyl group. | 17-phenyl-18,19,20-trinor-prostaglandin E2 |
3-methylflavone-8-carboxylic acid | A member of the class of flavones that is flavone substituted at position 3 by a methyl group and at position 8 by a carboxylic acid group. | 3-methylflavone-8-carboxylic acid |
amfenac | An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery. | amfenac |
demethylzeylasteral | A carbopolycyclic compound with formula C29H36O6, originally isolated from Tripterygium wilfordii. | demethylzeylasteral |
jasmonic acid | An oxo monocarboxylic acid that is (3-oxocyclopentyl)acetic acid substituted by a (2Z)-pent-2-en-1-yl group at position 2 of the cyclopentane ring. | jasmonic acid |
ketoprofen | An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2. | ketoprofen |
spiculoic acid a | A carbobicyclic compound that is 2,3,3a,4,5,7a-hexahydro-1H-indene substituted by ethyl groups at positions 3, 4, 5 and 7, a methyl group at position 1, an oxo group at position 2, a 2-phenylethenyl group at position 5 and a carboxy group at position 4 (the 1R,3R,3aS,4S,5R,7aS stereoisomer). Isolated from Plakortis angulospiculatus, it exhibits cytotoxicity against human breast cancer MCF-7 cells. | spiculoic acid A |
tuberonic acid | An oxo monocarboxylic acid that is (+)-7-isojasmonic acid in which one of the hydrogens of the side-chain methyl group is replaced by a hydroxy group. | tuberonic acid |
Research
Studies (6,730)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 445 (6.61) | 18.7374 |
1990's | 597 (8.87) | 18.2507 |
2000's | 1,818 (27.01) | 29.6817 |
2010's | 2,928 (43.51) | 24.3611 |
2020's | 942 (14.00) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 683 (9.72%) | 5.53% |
Reviews | 415 (5.91%) | 6.00% |
Case Studies | 183 (2.60%) | 4.05% |
Observational | 2 (0.03%) | 0.25% |
Other | 5,744 (81.74%) | 84.16% |